Market closedNon-fractional
XOMA/XOMA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About XOMA
XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Ticker
XOMA
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Emeryville, United States
Employees
13
Website
www.xoma.com
XOMA Metrics
BasicAdvanced
$298M
Market cap
-
P/E ratio
-$3.92
EPS
0.57
Beta
-
Dividend rate
Price and volume
Market cap
$298M
Beta
0.57
Financial strength
Current ratio
9.452
Quick ratio
9.425
Long term debt to equity
139.477
Total debt to equity
147.006
Interest coverage (TTM)
-5.55%
Management effectiveness
Return on assets (TTM)
-8.09%
Return on equity (TTM)
-40.24%
Valuation
Price to revenue (TTM)
50.726
Price to book
3.52
Price to tangible book (TTM)
3.52
Price to free cash flow (TTM)
-18.52
Growth
Revenue change (TTM)
73.10%
Earnings per share change (TTM)
48.77%
3-year revenue growth
-41.45%
3-year earnings per share growth
99.46%
What the Analysts think about XOMA
Analyst Ratings
Majority rating from 3 analysts.
XOMA Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.4M
-22.22%
Net income
-$8.5M
-57.71%
Profit margin
-607.14%
-45.63%
XOMA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.59
-$0.60
-$1.87
-$0.86
-
Expected
-$0.52
-$0.48
-$0.36
-$0.81
-$0.27
Surprise
14.34%
25.00%
416.57%
6.17%
-
XOMA News
AllArticlesVideos
XOMA Corporation: A Hold Rating With Steady Income From Preferred Shares
Seeking Alpha·1 week ago
XOMA Declares Quarterly Preferred Stock Dividends
GlobeNewsWire·2 weeks ago
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review Voucher
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for XOMA stock?
XOMA (XOMA) has a market cap of $298M as of July 06, 2024.
What is the P/E ratio for XOMA stock?
The price to earnings (P/E) ratio for XOMA (XOMA) stock is 0 as of July 06, 2024.
Does XOMA stock pay dividends?
No, XOMA (XOMA) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next XOMA dividend payment date?
XOMA (XOMA) stock does not pay dividends to its shareholders.
What is the beta indicator for XOMA?
XOMA (XOMA) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell XOMA stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.